Poor Understanding of Guidelines Results in Low National Use of Breast-Conserving Therapy

University of Pennsylvania Cancer Center
Ultima Vez Modificado: 18 de mayo del 1998

Translation for this article does not exist


Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015

Related News

ASCO Guidelines: Biomarker Use in Metastatic Breast CA Treatment

Jul 23, 2015

Hormone receptor status of metastases should be used to guide tx if supported by clinical scenario

ASCO Recommends Adjuvant Endocrine Therapy Extension

May 29, 2014

Modest survival advantage, lower recurrence seen with therapy for 10 years versus five years

BCS: Low Breast CA Recurrence Rate in Women ≤40 Years

Sep 8, 2011

BCT, mastectomy reveal similar survival rates in young women with early-stage breast cancer